Published: May 04, 2021
Selected Syneos Health
Company remains on track for potential approval in the US in August 2021
Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced the expansion of its leadership team with the appointment of experienced commercial industry leader, Lisa LaMond, as Vice President, Sales and Corporate Systems. The Company also announced its engagement of leading contract sales organization (CSO), Syneos Health, for field sales support and execution in the US for Vicineum.
Lisa LaMond brings invaluable experience in commercial pharmaceuticals to her role as Vice President, Sales and Corporate Systems. Prior to joining Sesen Bio, Ms. LaMond spent her career at Merck & Co. Inc. where she developed a diverse skillset across key commercial functions, as well as a deep understanding of the evolving healthcare environment and customer landscap
4 May in 16:35
Daily walks can become the key to longevity, scientists from the US National Cancer Institute and the Institute of Aging report.
The study lasted three years. Participants in the experiment over 40 years old wore special accelerometers. Thus, the data from the sensors allowed scientists to calculate the correlation between mortality and the number of steps, the Journal of the American Medical Association informs.
”8,000 steps reduce the risk of death from all causes in 51% of people, 12,000 steps reduce the risk by 65%, the American researchers report. 3725 views
Too few young men have received HPV vaccine, experts say
By
The HPV vaccine isn t reaching enough young American men, researchers report.
The vaccine protects against reproductive warts as well as cancers caused by human papillomavirus, or HPV, the most common sexually transmitted infection in the United States.
Advertisement
Many young women get the HPV vaccine to help protect them against cervical cancer, but numbers are much lower among young men, the Michigan Medicine-University of Michigan researchers found.
The U.S. Food and Drug Administration approved the vaccine for women in 2006 and expanded it to men in 2009.
When the HPV vaccine was first introduced, the main goal was to prevent cervical cancer.
Chernobyl radiation effects have not been passed on to next generation, study finds cnnphilippines.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cnnphilippines.com Daily Mail and Mail on Sunday newspapers.